Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-Cycloserine Enhancement in Social Phobia
NCT00633984Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Mar 2007
- Primary completion
- Mar 2012
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of d-cycloserine in Social Anxiety Disorder (SAD), sponsored by Massachusetts General Hospital. Started Mar 2007; status: completed.
02
Drugs
d-cycloserine
03
Conditions
Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on NCT00633984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00633984.